Sign in

You're signed outSign in or to get full access.

Xiaoming Ma

Director at Aquaron Acquisition
Board

About Xiaoming Ma

Xiaoming Ma (age 33) is an independent director of Aquaron Acquisition Corp. (AQUC) serving since May 2021. He holds a Master’s degree in Marine Technology (Shipping Management) from Delft University of Technology (2018) and a Bachelor’s degree in Naval Architecture and Marine Engineering from Harbin Engineering University (2015). His background spans commercial development, supply chain, and strategy roles in the marine/offshore sector, with current responsibilities as Sales Manager at Royal IHC Group (Shanghai).

Past Roles

OrganizationRoleTenureCommittees/Impact
Royal IHC GroupSales Manager (Shanghai)Sep 2020–presentCommercial leadership in marine/offshore solutions
Royal IHC GroupOutsourcing Management Lead (Kinderdijk)Sep 2019–Sep 2020Oversight of outsourcing and supply chain
Royal IHC GroupProposal ManagerApr 2019–Sep 2019Bid/proposal management
Royal IHC GroupAssistant General ManagerOct 2018–Apr 2019General management support
Royal IHC GroupBusiness Development ManagerOct 2018–May 2019Growth initiatives and BD
Royal IHC GroupStrategy ConsultantApr 2018–Nov 2018Strategic projects
Royal IHC GroupPurchaser & Supply Chain AnalystNov 2017–Apr 2018Procurement & analytics
Hengxin Offshore & Marine Engineering (Europe)Sales & BD Manager (Rotterdam)Apr 2016–Dec 2016European BD in offshore/marine

External Roles

OrganizationPositionSectorNotes
Royal IHC GroupSales Manager (Shanghai)Marine/OffshoreCurrent role since Sep 2020

Board Governance

  • Independence: Ma is one of three independent directors (with Yanyan Lin and Yang Wang) under Nasdaq/SEC rules. Independent directors have regularly scheduled meetings at which only independent directors are present.
  • Tenure: Director since May 2021; nominated for re‑election at the 2025 annual meeting.
  • Committee assignments:
    • Audit Committee member; committee held no formal meetings in 2024; Chair: Yanyan Lin; Lin designated “audit committee financial expert.”
    • Nominating Committee member; held no meetings in 2024; Chair: Yang Wang.
    • Compensation Committee member; did not meet in 2024; Chair: Yang Wang.
  • Voting dynamics: Initial stockholders and affiliates intend to vote in favor of proposals, with sponsor control and majority ownership materially influencing outcomes.
CommitteeRoleChair2024 Meetings
AuditMemberYanyan LinNone
NominatingMemberYang WangNone
CompensationMemberYang WangNone

Fixed Compensation

ComponentAmount/Terms
Annual cash retainerNone (SPAC policy: no compensation to directors prior to business combination)
Committee membership feesNone
Committee chair feesNone (Ma is not a chair)
Meeting feesNone

Performance Compensation

Instrument/MetricDetail
Equity grants (RSUs/PSUs)None prior to business combination
OptionsNone prior to business combination
Performance metrics (TSR, revenue, EBITDA, ESG)Not applicable (no director performance pay disclosed)
Vesting/COC/clawbacksNot applicable (no awards)

Other Directorships & Interlocks

CompanyTypeRoleNotes
None disclosedNo public company directorships or interlocks disclosed in proxy/10‑K for Ma

Expertise & Qualifications

  • Marine/offshore industry experience; commercial and business development focus across Europe and China.
  • Supply chain, outsourcing, proposal management, and strategy execution experience.
  • Education: MSc Marine Technology (Delft, 2018); BEng Naval Architecture (Harbin, 2015).
  • Board independence; member of Audit, Nominating, and Compensation Committees.

Equity Ownership

HolderBeneficial Shares% of OutstandingNotes
Xiaoming Ma5,000<1%As of record date Apr 2, 2025; outstanding shares 2,428,412
Aquaron Investments LLC (Sponsor)1,578,06064.98%Sponsor control; includes 268,765 private unit shares

Governance Assessment

  • Board/committee activity: All three key committees (Audit, Nominating, Compensation) reported no formal meetings in 2024, indicating low formal oversight cadence during the period.
  • Internal controls: Company disclosed material weaknesses in internal control over financial reporting and concluded disclosure controls were not effective as of Dec 31, 2024.
  • D&O insurance: Directors and officers liability insurance expired on Jan 4, 2024 and was not renewed, increasing governance risk and potential personal exposure.
  • Listing status: AQUC was delisted from Nasdaq on Mar 7, 2025; securities now quoted OTC (AQUC/AQUNU/AQUNR), which may hinder transaction execution and investor liquidity.
  • Capital structure/redemptions: High public share redemptions in 2023–2024 reduced public float to 805,352 shares; trust balance ~$9.36M as of Mar 31, 2025.
  • Sponsor influence/conflicts: Sponsor and insiders agreed to vote for business combinations; sponsor provided/holds convertible notes and extension funding (Bestpath/Huture notes) to prolong the combination period, which can create perceived conflicts and alignment questions.
  • CFIUS/foreign control sensitivity: Sponsor is controlled by a PRC resident; while current target is non‑U.S., foreign investment considerations remain a diligence factor for future combinations.
  • Positive governance elements: Ma is independent; Audit Committee includes a designated financial expert (Yanyan Lin); policies require fairness opinions and independent director approval for any affiliate business combinations; code of ethics in place.

Implications: For investors, Ma’s independence and committee roles are positives, but committee inactivity, internal control weaknesses, D&O insurance lapse, and the company’s delisting and sponsor-dominant voting position are material governance red flags that can impair board effectiveness and investor confidence in transaction execution.